INTRODUCTION {#SEC1}
============

Gene duplication and subsequent functional divergence of paralogs is one of the main sources of evolutionary diversity in all living systems ([@B1]). Two models of functional adaptation are commonly considered: subfunctionalization, wherein the duplicates partition the ancestral function, and neofunctionalization, wherein one duplicate acquires a novel function. The evolution of the NusG family of transcription elongation factors provides a particularly striking example of neofunctionalization accompanied by transformation ([@B2]), the ability of one duplicate to undergo an α-to-β fold conversion that bestows a new function.

Proteins from the NusG/Spt5 family are the only known examples of universally conserved transcriptional regulators ([@B3]). NusG-like proteins are composed of an α/β N-terminal domain (NTD) and a β-barrel C-terminal domain (CTD) that contains a Kyprides-Onzonis-Woese (KOW) motif commonly found in ribosomal proteins ([@B4]). The two domains are connected by a flexible linker and together enable uninterrupted synthesis of long RNA molecules in synchrony with ongoing cellular processes, such as translation in prokaryotes and splicing and polyadenylation in eukaryotes. The NTDs bind to the two pincers of elongating RNA polymerase (RNAP), forming processivity clamps around the nucleic-acid chains ([@B3]). The location of the RNAP-binding site and the mode of NTD action appear to be ubiquitous among all NusG proteins ([@B5]). In contrast, the CTDs interact with an astonishingly diverse set of cellular partners that include the bacterial ribosome ([@B6]) and yeast splicing and capping factors ([@B7]).

*Escherichia coli* NusG and its paralog RfaH are the best-characterized transcription elongation factors. RfaH and NusG share binding sites on the transcription elongation complex (TEC) and the ribosome, as well as the molecular mechanism of RNAP modification into a highly processive, pause-resistant state. Strikingly, however, the cellular functions of NusG and RfaH are not only different but opposite (Figure [1](#F1){ref-type="fig"}). NusG is an essential and abundant (∼5,000 copies/cell; ([@B8])) protein that associates with RNAP transcribing almost all genes, displaying no apparent sequence specificity ([@B9]). The NusG CTD binds to the transcription termination factor Rho, stimulating Rho activity *in vitro* and *in vivo* ([@B10]). Together, NusG and Rho silence foreign DNA ([@B11]); NusG becomes largely dispensable in a genome-reduced *E. coli* strain from which the horizontally-acquired regions have been removed ([@B11]). By contrast, RfaH is scarce (50 copies/cell; ([@B8])), does not bind to Rho (at least at physiological conditions/concentrations), and reduces Rho-dependent termination *in vitro* ([@B12]), likely by disfavoring the paused RNAP state which is a target for Rho. RfaH is recruited to only those few operons that contain a 12-nt-long *ops* DNA element in their leader regions ([@B13]) and strongly activates their expression by abolishing Rho-dependent termination ([@B14]) and increasing translation ([@B15]); RfaH excludes NusG through direct competition for the shared binding site on RNAP ([@B13]) and is thought to directly recruit the 30S subunit of the ribosome through protein-protein interactions between the CTD and the ribosomal protein S10 ([@B15]). Every gene that RfaH controls is horizontally transferred, and many of them are essential for virulence; loss of *rfaH* attenuates virulence in *E. coli, Salmonella* and *Klebsiella pneumoniae* ([@B16]--[@B18]).

![Regulatory mechanisms of RfaH and NusG.](gkx523fig1){#F1}

Since RfaH directly opposes the action of the essential NusG, RfaH activity needs to be tightly controlled. This is accomplished by a combination of much reduced levels and exquisite specificity of RfaH, which depends absolutely on the *ops* signal for recruitment to the transcription elongation complex (TEC). A basic patch on the RfaH NTD recognizes the *ops* bases ([@B19]) on the non-template DNA strand in the transcription bubble exposed on the surface of RNAP paused at the *ops* site ([@B12]). These residues are not conserved in NusG, and this divergence could explain RfaH preference for a specific site. However, the *ops* plays another, more critical role in RfaH recruitment: contacts with *ops* transform a silent, autoinhibited RfaH into an activated state capable of binding to RNAP ([@B20]). In contrast to *E. coli* NusG, in which the freely rotating NTD and CTD are connected by a highly flexible linker ([@B21]), the CTD in free RfaH is folded as an α-helical hairpin that forms a large hydrophobic interdomain interface (IDI), masking the RNAP-binding site on the NTD ([@B20]). The domain dissociation is triggered by binding to the *ops* element and is a prerequisite for NTD recruitment to RNAP; similarly to NusG, the isolated RfaH NTD binds to the TEC indiscriminately, bypassing the need for activation ([@B20]).

The interconversion between the two different states of the CTD is a signature of RfaH action, with both states playing essential roles. The isolated CTDs of all NusG-like proteins, including RfaH, fold as nearly superimposable β-barrels. The β-CTD of RfaH binds to the ribosomal protein S10 to recruit the ribosome to the nascent mRNA, the most critical activity of RfaH; analogous NusG-S10 contacts are thought to couple transcription to translation. The α-CTD restricts RfaH action to a handful of genes, preserving the essential regulation by NusG. Thus, attainment of the transforming capability that is essential for autoinhibition was the key step in the evolution of dedicated RfaH-like regulators acting alongside NusG. The determinants of the dramatic refolding behavior of RfaH CTD are not yet known, although several molecular dynamics (MD) studies provided insights into this phenomenon. In this work, we carried out an analysis of bacterial NusG and RfaH subfamilies to identify specific residues that may define their different folds and respective properties. We show that substitutions of RfaH residues predicted to play key roles in maintenance of the interdomain contacts, Ile93 and Phe130, for their NusG counterparts relaxes the requirement for *ops*, 'converting' RfaH into a non-specific regulator in which the IDI is partially destabilized.

MATERIALS AND METHODS {#SEC2}
=====================

Plasmids and reagents {#SEC2-1}
---------------------

All general reagents were obtained from Sigma Aldrich (St. Louis, MO, USA) and ThermoFisher Scientific (Pittsburgh, PA, USA); NTPs---from GE Healthcare (Piscataway, NJ, USA); and \[α^32^P\]-CTP---from Perkin Elmer (Boston, MA, USA). PCR reagents, restriction and modification enzymes were from NEB and Roche (Indianapolis, IN, USA). Ni-sepharose resin, HiTrap Heparin HP and Resource Q columns were from GE Healthcare. Oligonucleotides were obtained from Sigma Aldrich. DNA purification kits were from Qiagen (Valencia, CA) and Promega (Madison, WI, USA).

Proteins {#SEC2-2}
--------

*Escherichia coli* RNAP core and σ^70^, WT RfaH and isolated domains were purified as in ([@B20]). RfaH variants I93E (pIA1253) and F130V (pIA1254) were constructed by site-directed mutagenesis in pIA751; these proteins carry a His~6~ tag followed by a TEV cleavage site and were purified from the XJb (λDE3) strain as described previously ([@B19]). To remove His tags, His~6~ tagged TEV protease (100 μg) was incubated with the protein sample (∼8 mg) at 4°C for 20 h. The cleaved-off His~6~ tag, the uncut His~6~-protein, and (His-tagged) TEV were removed by adsorption to Ni-sepharose. Proteins were dialyzed into storage buffer (50% glycerol, 100 mM NaCl, 10 mM Tris--Cl pH 7.9, 0.1 mM EDTA, 0.1 mM DTT) and stored at --20°C.

Template preparation {#SEC2-3}
--------------------

Templates for *in vitro* transcription were generated by PCR amplification from pIA1087 (WT *ops*) and pZL23 (G8C *ops*) reporter plasmids encoding the *rfb* leader region-*lux* operon fusion under control of *E. coli* P~BAD~ promoter ([@B15]). To enable efficient transcription and the formation of halted radiolabeled TEC, the first PCR step was performed with a 73-nt long primer adding the T7A1 promoter and a 24-nt long U-less region to the *rfb* leader region (2536; AAAAAGAGTATTGACTTAAAGTCTAACCTATAGGATACTTA CAGCCATCGAGCAGGCAGCGGCAAAGCCATGG) and a reverse primer (2537; AAATAAGCGGCTCTCAGTTT). Following the removal of primers, the second step PCR was performed with primer 2537 and a forward primer 2499 (AAAAAGAGTATTGACTTAAAG). The amplified sequence spans --46 through +79 positions relative to the T7A1 transcription start site.

Single-round transcription elongation assays {#SEC2-4}
--------------------------------------------

Linear DNA template (30 nM), holo RNAP (40 nM), ApU (100 μM), and starting NTP substrates (1 μM CTP, 5 μM ATP and UTP, 10 μCi \[α^32^P\]-CTP, 3000 Ci/mmol) were mixed in 100 μl of TGA2 (20 mM Tris-acetate, 20 mM Na-acetate, 2 mM Mg-acetate, 5% glycerol, 1 mM DTT, 0.1 mM EDTA, pH 7.9). Reactions were incubated for 15 min at 37°C; thus-halted TECs were stored on ice. RfaH variants (or an equal volume of storage buffer) were added to the TEC, followed by a 2-min incubation at 37°C. Transcription was restarted by addition of nucleotides (10 μM GTP, 150 μM ATP, CTP and UTP) and rifapentin to 25 μg/ml. Samples were removed at time points indicated in the figures and quenched by addition of an equal volume of STOP buffer (10 M urea, 60 mM EDTA, 45 mM Tris-borate; pH 8.3). Samples were heated for 2 min at 95°C and separated by electrophoresis in denaturing 8% acrylamide (19:1) gels (7 M urea, 0.5× TBE). The gels were dried and RNA products were visualized and quantified using the FLA9000 Phosphorimaging System, ImageQuant Software, and Microsoft Excel.

Chymotrypsin digestion {#SEC2-5}
----------------------

Chymotrypsin (Sigma Aldrich) was dissolved in 1 mM HCl (as recommended by the manufacturer) at 2 mg/ml and stored at --80°C in single-use aliquots. Prior to use, an aliquot was diluted into PBS, pH 7.4 (ThermoFisher Scientific) on ice. 9 μl of chymotrypsin in PBS (0.2 mg enzyme) were mixed with 6 μl of RfaH variants or domains (∼2 mg protein) in storage buffer (50% glycerol, 100 mM NaCl, 10 mM Tris--Cl pH 7.9, 0.1 mM EDTA, 0.1 mM DTT). The volume used was dictated by the concentration of the least soluble RfaH variant, I93E; higher glycerol concentrations were found to inhibit chymotrypsin cleavage. To the control samples, only PBS was added. The reactions were incubated at 37°C for 10, 20, 40 and 80 min and stopped by the addition of 5 mM PMSF and LDS loading dye (ThermoFisher Scientific). Samples were heated at 75°C for 5 min and 8 μl were loaded onto 4--12% Bis--Tris gels, which were run in 1× SDS-MES buffer at 180 V. The gels were stained with GelCode Blue (ThermoFisher Scientific). With each RfaH variant, the assay was repeated at least three times; the WT protein was assayed in parallel every time.

Calculation of entropy and conservation score {#SEC2-6}
---------------------------------------------

RfaH sequences were aligned with implemented tools in ICM ([@B22]). Based on the alignment, we assessed two quantitative characteristics of diversity: *Entropy* and *Conservation score*. Entropy was calculated according to formula ([@B1]), where $\documentclass[12pt]{minimal}
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Calculation of interdomain interface contact area {#SEC2-7}
-------------------------------------------------

The IDI contact areas of residues of RfaH were calculated with implemented tools of ICM ([@B24]). First, the solvent-accessible areas of each residues were calculated using a water probe with a radius of 1.4 Å in the closed state, in which the CTD and the NTD interact. Then solvent-accessible areas were calculated upon separation of the two domains. The difference between the two represents the IDI contact areas of residues.

Calculation of domain binding energy contributions (ΔΔG*~bind~*) of residues {#SEC2-8}
----------------------------------------------------------------------------

ΔΔG*~bind~* of each residue was calculated with implemented tools of ICM by evaluating the effect on the binding free energy upon its substitution with a glycine, using formulas (3) and (4), where$$\documentclass[12pt]{minimal}
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RESULTS {#SEC3}
=======

We first performed an *in silico* analysis of the RfaH and NusG subfamilies, in the following order: (i) to identify amino acid residues that are conserved in the RfaH subfamily; (ii) to assess their potential to disrupt the closed, α-helical state but not the open, β-barrel state; (iii) to simulate the structural and energetic effects of a substitution at the IDI in the closed state; and (iv) to identify the equivalent *E. coli* NusG residues that are conserved within the NusG subfamily yet distinct from those in RfaH.

Identifying residues that contribute to the closed-state stabilization in RfaH {#SEC3-1}
------------------------------------------------------------------------------

1383 sequences of RfaH proteins in different organisms were obtained from InterPro ([@B25]), and duplicate identical sequences were removed. Alignment of the remaining 751 sequences built with ICM ([@B26],[@B27]) identified ∼90% similarity-conservation for 36 positions (Figure [2](#F2){ref-type="fig"}). To quantitatively assess diversity, we calculated the entropy and the conservation score ([Supplementary Table S1](#sup1){ref-type="supplementary-material"}) of each RfaH residue (see Materials and Methods). Conserved residues have low entropies and high conservation scores; we set the conservation score \>0.8 and entropy \<0.9 as filters in this analysis.

![The key features of the RfaH and NusG families. (**A**) Structural alignment of *E. coli* RfaH and NusG is shown in the middle. The NTD alignment was derived from the superposition of PDBs 2OUG (RfaH) and 2K06 (NusG), and the CTD alignment was derived from the superposition of PDBs 2LCL (RfaH) and 2KVQ (NusG). A profile above the alignment was generated from the sequence alignment of 751 RfaH sequences, while profile underneath was generated from the sequence alignment of 9204 NusG sequences. Red circles in the middle indicate the ΔΔG*~bind~* value; large, \>1.5 kcal/mol, small, 1--1.5 kcal/mol. IDI contact areas are shown as blue circles; large, IDI contact areas \>50 Å^2^, small, \<50 Å^2^. The residues with large IDI contact areas and ΔΔG*~bind~* are shaded in magenta and labeled with the residue number in RfaH.](gkx523fig2){#F2}

The unique closed state of RfaH is stabilized by interactions between the NTD and the α-helical CTD. To identify the residues that make key contributions to the closed-state stabilization, their IDI contact areas were calculated (see Materials and Methods). Residues with larger IDI contact areas are more likely to be directly involved in stabilizing the α-state of CTD and thus the closed state of RfaH. The IDI contact areas of each residue are shown as blue circles in Figure [2](#F2){ref-type="fig"}; large circles indicate IDI contact areas larger than 50 Å^2^; small circles, IDI contact areas between 0 and 50 Å^2^. A contact area of 50 Å^2^ was chosen as a filter.

To assess the energetic contribution of individual residues to the closed-state stabilization, we calculated the binding free energy change upon *in silico* substitution of each residue with glycine ([@B28]). Substitution of a residue important for domain interface stability is characterized by a positive ΔΔG*~bind~* value, indicated with a red circle in Figure [2](#F2){ref-type="fig"}. Large dots correspond to residues with ΔΔG*~bind~* larger than 1.5 kcal/mol (chosen as a filter), while small circles correspond to residues with ΔΔG*~bind~* between 1 and 1.5 kcal/mol. This analysis identified nine RfaH residues that display large IDI contact areas and ΔΔG*~bind~*: Phe51, Pro52, Phe81, Ile93, Leu96, Phe126, Phe130, Arg138, Leu142 (shown in magenta boxes in Figure [2](#F2){ref-type="fig"}). Leu96 and Phe126 residues were filtered out because their entropy scores (1 and 1.6, respectively) exceeded 0.9 ([Supplementary Table S1](#sup1){ref-type="supplementary-material"}).

In summary, seven RfaH residues passed through the selected filters (conservation score \> 0.8; entropy \< 0.9, IDI contact area \> 50 Å^2^, ΔΔG*~bind~* \> 1.5 kcal/mol). Among these residues, Ile93, Phe130, Arg138 and Leu142 have been proposed to play key roles in the stabilization of the IDI, based on computational and experimental evidence ([@B15],[@B29]--[@B34]).

Identifying key residues that define RfaH and NusG subfamilies {#SEC3-2}
--------------------------------------------------------------

Next, we sought to determine which of the seven selected residues are likely to be required for the formation of the RfaH-like closed state, and are thus different in NusG, in which the NTD and CTD do not interact ([@B21]). To identify NusG residues at the positions corresponding to Phe51, Pro52, Ile93, Phe130, Arg138 and Leu142 in RfaH, we performed structural alignment of *E. coli* RfaH and NusG ([@B35]). This analysis (Figure [2](#F2){ref-type="fig"}) revealed that Phe51, Pro52 and Arg138 residues are identical between RfaH and NusG, and are therefore unlikely to make specific contributions to the autoinhibitory state of RfaH. By contrast, the remaining four residues differ between the two proteins. We next performed sequence alignment of 9204 bacterial NusG proteins (Figure [2](#F2){ref-type="fig"}) to determine which of these residues should be selected for experimental validation. We found that NusG residues corresponding to RfaH Ile93 and Phe130 (Glu107 and Val148) are conserved in the alignment of NusG sequences (with Val or homologous Ile at position 148), whereas residues corresponding to Phe81 and Leu142 are not. Thus, we focused our functional analysis on Ile93 and Phe130, substituting these residues with Glu and Val, respectively, and testing the altered proteins *in vitro*. We expected that thus-altered RfaH proteins will have a weakened IDI and therefore sequence-independent, NusG-like recruitment to the TEC.

NusG-like RfaH variants are fully functional on an *ops*-containing template {#SEC3-3}
----------------------------------------------------------------------------

We first tested the altered proteins during transcription *in vitro*. Because the affected residues are not involved in interactions with DNA or RNAP ([Supplementary Figure S1](#sup1){ref-type="supplementary-material"}), the mutant proteins should be recruited to RNAP paused at the *ops* site similarly to the wild-type (WT) RfaH, as long as their structure is not altered. To test this, we carried out single-round elongation assays on a template that contains the WT *ops* element (Figure [3](#F3){ref-type="fig"}). On this template, RNAP can be stalled at position A24 in the absence of UTP and restarted upon the addition of all NTPs. In the absence of transcription factors, RNAP pauses at C36 and U38 within the *ops* element, before making the full-length RNA of 79 nt; a strong arrest is observed at C71, likely because RNAP progression is hindered in the absence of the downstream duplex DNA ([@B36]); pausing at these sites is accentuated at low \[GTP\], the incoming substrate, as used in this assay. Addition of wild-type RfaH or the isolated NTD reduces pausing at U38 ∼3-fold, but delays RNAP 1 nt downstream, presumably via RfaH NTD-DNA interactions that must be broken to allow RNAP escape ([@B19]); this delay is not sensitive to NTP concentrations. I93E and F130V RfaH variants exhibit similar behavior at U38 and G39, whereas NusG does not. These results indicate that I93E and F130V substitutions do not interfere with RfaH recruitment to the TEC and antipausing modification of RNAP.

![Effects of RfaH variants on pausing at the *ops* site. (Top) Transcript generated from the T7A1 promoter on a linear DNA template; transcription start site (a bent arrow), *ops* element (gray box), and transcript end are indicated on top. (Bottom) Halted A24 TECs were formed as described in Materials and Methods. Elongation was restarted upon addition of NTPs and rifapentin in the presence of the indicated transcription factor. Aliquots were withdrawn at times indicated above each lane (in s) and analyzed on an 8% denaturing gel. Positions of the paused and run-off transcripts are indicated with arrows; the position of the RfaH-induced pause at G39, with a circle. Pausing at *ops* (U38; fraction of total RNA) and arrival at the C71 position (fraction of final at 180 sec) were quantified to assess the anti-pausing effects of elongation factors; 30-s values are shown below each panel. The experiment was repeated three times; errors were \<15%.](gkx523fig3){#F3}

NusG-like RfaH variants can be recruited to TEC in the absence of *ops* {#SEC3-4}
-----------------------------------------------------------------------

Our analysis suggested that Glu93 and Val130 could disfavor the autoinhibited state of RfaH, thereby facilitating sequence-independent (NusG-like) recruitment to RNAP. To test this hypothesis, we used a template in which an invariant *ops* residue G8 was substituted with C (Figure [4](#F4){ref-type="fig"}). This substitution preserves the pausing pattern but abolishes recruitment to *ops*, and thus anti-pausing activity, of WT RfaH. By contrast, the isolated NTD and NusG increase the rate of RNAP elongation, leading to faster arrival at C71, a ∼2.5-fold effect at the 30-s timepoint (Figure [4](#F4){ref-type="fig"}). In support of our prediction, I93E and F130V RfaH variants exhibit intermediate phenotypes, speeding arrival at C71 1.6- and 2-fold, respectively. These results indicate that a single substitution of a key RfaH residue for its NusG counterpart is sufficient to allow for *ops*-independent recruitment. Conversely, this suggests that a single mutation in the nascent NusG duplicate could enable the formation of the silenced, autoinhibited state.

![Effects of RfaH variants on pausing in the absence of *ops*. (**A**) The experiment was performed as in Figure [3](#F3){ref-type="fig"}, except that a mutant *ops* element, with G8 substituted for a C (white oval), was used. (**B**) Arrival at the C71 position was quantified; the error bars are omitted for clarity. A representative example (30-s) is shown below in panel A, along with the fraction of U38 RNA; errors are standard deviations calculated from three repeats.](gkx523fig4){#F4}

Probing RNAP-binding site accessibility by proteolysis {#SEC3-5}
------------------------------------------------------

Our observations that RfaH I93E and F130V variants facilitate RNA synthesis on the mutant *ops* template (Figure [4](#F4){ref-type="fig"}) are consistent with the hypothesis that these substitutions destabilize the domain interface, leading to spontaneous, *ops*-independent exposure of the RNAP-binding surface on the NTD. Similarly to the isolated NTD ([@B20]), these variants are prone to aggregation and precipitate at concentrations \>10 μM. The limited solubility of altered RfaH variants does not interfere with *in vitro* transcription analysis but hinders their structural characterization. Furthermore, the conformational transitions that accompany RfaH domain dissociation are complex, involving CTD refolding that may proceed via at least one intermediate ([@B32]).

We therefore sought an approach to directly probe the accessibility of the RNAP-binding site on the NTD at low protein concentrations. The β' clamp helices (CH) domain interacts with a cluster of aromatic residues in the NTD ([@B20]); substitutions of these residues abolish RfaH recruitment ([@B19]). To directly probe the solvent accessibility of this site, we used chymotrypsin, a serine protease that preferentially binds to and cleaves the C-termini of aromatic residues ([@B37]). In full-length RfaH, all aromatic residues except Tyr99 are buried, whereas upon domain separation, the residues that comprise the RNAP-binding site on the NTD and at least two Phe residues on the CTD should become exposed and thus accessible to chymotrypsin (Figure [5A](#F5){ref-type="fig"}).

![Probing the RfaH domain dissociation by chymotrypsin digestion. (**A**) Accessibility of aromatic residues in the full length RfaH and the isolated domains. The NTD is shown in gray and the CTD in cyan; both states of the CTD are shown. The aromatic residues are shown as sticks (red in the NTD; blue in the CTD), with their surfaces hidden. This figure was prepared with Pymol 1.8.2.3 (Schrödinger, LLC) using PDB IDs 2OUG and 2LCL. (**B**) Chymotrypsin cleavage of selected protein variants. The assays were performed as described in Materials and Methods; the samples were analyzed on 17-well 4--12% Bis--Tris gels. The WT, 193E and F130V samples were analyzed on one gel, and the isolated domains (along with the full-length protein, not shown) on another. Chymotrypsin is visible above the uncut proteins.](gkx523fig5){#F5}

The full-length WT RfaH was highly resistant to chymotrypsin, requiring large concentrations of protease for cleavage (visible on the gel; Figure [5B](#F5){ref-type="fig"}). By contrast, the isolated domains were rapidly cleaved, confirming the utility of this approach. The I93E and F130V substitutions conferred increased susceptibility to chymotrypsin cleavage as compared to the WT RfaH (Figure [5B](#F5){ref-type="fig"}). These results indicate that these substitutions weaken the domain interface, promoting CTD dissociation and subsequent RNAP binding. We note that while we cannot identify which form of the CTD is being cleaved (since Phe123 and Phe126 could be accessible in either the α- or β-state; Figure [5A](#F5){ref-type="fig"}) by gel analysis, this approach could be adapted to monitor CTD folding by measuring the exposure of Phe130, which is part of the hydrophobic core of the β-barrel CTD ([@B15]).

We argue that proteolytic enzymes are better suited for probing the accessibility of protein-binding interfaces than small molecules, e.g. hydrophobic dyes used in differential scanning fluorimetry ([@B38]). Enzymatic probing can be carried out under conditions that mimic those used for functional assays (concentrations, temperature, etc.) and allows for a more realistic assessment of binding-site exposure to a large protein ligand.

DISCUSSION {#SEC4}
==========

Autoinhibition is a widespread phenomenon that links protein activity to the presence of a cognate signal. During autoinhibition, intramolecular interactions between separate regions of a polypeptide negatively regulate its function, ensuring that activation is achieved only in response to proper physiological signals. Inhibition of ligand binding is the most common class of autoinhibition ([@B39]), where nucleic acid or protein interaction sites on a functional domain (FD) are masked by an inhibitory module (IM). Autoinhibition frequently modulates binding to DNA in transcription factors, such as σ^70^ ([@B40]) and Ets factors ([@B41],[@B42]). Evolution of an autoinhibited state was essential for the diversification of a nascent paralog of NusG, a housekeeping transcription elongation factor that regulates the synthesis of most cellular RNAs, into a dedicated regulator that controls just a handful of genes. In this study, we sought to identify the determinants of autoinhibition using *E. coli* RfaH, a highly specialized NusG paralog in which the relief of autoinhibition is achieved via interactions with a specific target DNA sequence presented on the surface of the elongating RNAP.

Structural determinants of RfaH autoinhibition {#SEC4-1}
----------------------------------------------

*Escherichia coli* RfaH is a transformer protein that exists in two alternative states ([@B2]). In the closed, autoinhibited state, the α-helical CTD masks the RNAP-binding site on the NTD. Interactions with the *ops* DNA induce opening of the RfaH IDI, releasing the CTD that subsequently refolds into a β-barrel. Our research has demonstrated that the stability of the RfaH IDI is responsible for the maintenance of the alternative α-helical CTD fold, autoinhibition, and resulting sequence specificity all lacked by its NusG-like ancestor ([@B15],[@B20],[@B43]). Here, we show that the primary determinants of this increased stability can be identified through a synergistic approach unifying phylogenetic, structural, and biochemical evidence. This suggests that such an approach might prove useful in studying other examples of protein autoinhibition thought to be involved in many fundamental cellular signaling mechanisms ([@B44]), virulence ([@B45]), and disease states ([@B46]--[@B48]).

Here, we have identified two RfaH residues, Ile93 and Phe130, predicted to be uniquely important for IDI stability. We show that substitution of either residue for its NusG counterpart (I93E and F130V) alters the stability of the RfaH IDI so drastically as to convert the protein into a NusG-like regulator, with the loss of the sequence-dependent recruitment to the TEC characteristic of the former. It should also be acknowledged that many researchers, including ourselves, have studied the two native-state conformations of RfaH and potential mechanisms of interconversion between them using a variety of MD simulations. These simulations, to our knowledge, have only probed the thermodynamics and kinetics of RfaH (re)folding in the absence of DNA, the ligand that triggers the relief of autoinhibition. Nonetheless, they have yielded several testable predictions that our study has been able to validate and place within a broader context.

Chapagain and colleagues devised targeted and steered MD simulations showing that the breaking of contacts in the IDI presents the major thermodynamic barrier to the conversion of the RfaH CTD from α-helix to β-barrel, and also that Phe130 plays an important role in weakening of these contacts ([@B30]). We reached the same conclusions independently using a dual-basin structure-based simulation ([@B32]). Chapagain and colleagues also found that a nascent interdomain contact between Ile93 and Phe126 exposes an otherwise buried hydrophobic core in the NTD that prevents its binding to the β' CH domain ([@B30]). These findings are supported by our demonstration of the importance of the Phe130 and Ile93 residues for IDI stability (Figure [5](#F5){ref-type="fig"}) and autoinhibition (Figure [4](#F4){ref-type="fig"}).

Still other studies explain not only why the Phe130 residue is so vital for RfaH-style functionality, but also why its substitution for valine proves so destructive. Valine and isoleucine residues strongly favor a β secondary structure to an α one ([@B49]), and F130V possesses a new valine residue adjacent to an isoleucine (at 129), increasing the propensity of the RfaH CTD to fold as a β-structure (the only one that the NusG CTD forms). Moreover, while three MD simulations using different methodologies, dual-basin structure-based ([@B32]), Markov State Model and transition path theory ([@B31]), and coarse-grained off-lattice MD modeling ([@B33]), identified multiple candidate mechanisms for the α→β conversion of RfaH, all of these mechanisms had as their first step the formation of a β-sheet involving Phe130.

Our results also verify and build upon broader findings regarding the fundamental properties and regulation of autoinhibited proteins generally. A study by Gsponer and colleagues ([@B44]) found that when an interface exists between the FD and at least one IM, (i) residues in the IM-FD IDI are conserved regardless of their diversity across homologs in the IM and (ii) intrinsically disordered IMs are preferable to structured ones since greater variation in intrinsic disorder should allow for fine-tuning of the equilibrium between active and inactive states on which the regulation depends. If we define the RfaH IM to include both its transformable CTD and the flexible linker (the NTD is of course the FD, as it confers the desired sequence-specific recruitment to the TEC), then our validation of (i) is apparent from the phylogenetic analysis (Figure [2](#F2){ref-type="fig"}) and the relief of autoinhibition resulting from changes of the IDI residues (Figure [4](#F4){ref-type="fig"}). The recent μs-timescale MD simulation by Xun *et al.* demonstrated that two intrinsically disordered regions (IDRs) are necessary to stabilize the α-form of the CTD ([@B34]), with Phe130 making a contact with IDR1. The status of the linker as an IDR is supported by its tolerance to deletions and insertions and its absence from X-ray and NMR structures ([@B15],[@B20]), implying its flexibility. Thus, the available data validate (ii) as a key feature of IMs, exemplified by RfaH.

Autoinhibition in regulation of NusG-like proteins {#SEC4-2}
--------------------------------------------------

While we have focused on converting RfaH into NusG, it is also interesting to ask the reverse question: could NusG be converted into RfaH, conferring autoinhibition in the process? Our results would indicate that if the IDI contacts can be made sufficiently strong, then the reverse conversion should be possible. Indeed, a recent report by Rösch and co-authors showed that *Thermotoga maritima* NusG is autoinhibited due to particularly strong IDI interactions absent from all other NusG variants yet found ([@B50]). Interactions between the NTD and the β-barrel CTD of *T. maritima* NusG mask the binding sites for Rho, S10, and RNAP and must be broken to attain the active state. This autoinhibited state is argued to thermally stabilize the protein, rather than tune its regulatory properties, a function that may be critically important in the hyperthermophilic niche of *T. maritima* ([@B50]).

By contrast, autoinhibition is critical for delineating RfaH targets and conferring the dramatic activation of gene expression by RfaH. The closed state of RfaH masks the binding sites for both its cellular protein targets, RNAP and the ribosome. While the contact site with RNAP is merely masked by the IM, and can be exposed upon proteolytic removal of the CTD and part of the linker ([@B20]), the ribosome binding site is simply missing in the α-helical CTD. A complete refolding of the RfaH CTD into a β-barrel creates the interaction surface for S10 ([@B15]), with the resulting CTD-S10 complex closely resembling that formed by NusG ([@B6]). This transformation is critical for RfaH function as it enables recruitment of the 30S ribosomal subunit to mRNAs that lack ribosome-binding sequences ([@B15]); in fact, expression of a reporter gene can be made dependent on RfaH by adding the *ops* sequence and removing the ribosome binding sequence in front of heterologous reporter genes ([@B15]). Dramatic activation of translation by RfaH is thought to insulate its target RNAs from premature termination by Rho ([@B14]), which silences these and other foreign genes ([@B11]). Curiously, *Clostridium botulinum* Rho has been recently reported to undergo a prion-like transformation that inhibits its function ([@B51]), highlighting the widespread role of dramatic conformational changes in the regulation of bacterial gene expression.

Specialized NusG paralogs present in diverse bacterial phyla regulate expression of genes encoding biosynthesis of capsules in *K. pneumoniae* ([@B16]) and *Bacteroides fragilis* ([@B52]), toxins in *E. coli* ([@B53]) and *Serratia entomophila* ([@B54]), and antibiotics in *Myxococcus xanthus* ([@B55]) and *Bacillus amyloliquefaciens* ([@B56]). Some RfaH homologs are encoded on large conjugative multidrug-resistance plasmids and have been proposed to activate the pilus biosynthesis operons ([@B3]), by analogy to RfaH-mediated activation of the *tra* operon on F plasmid ([@B53]). Thus, in addition to their well-established roles in virulence ([@B16]--[@B18]), RfaH-like regulators may also be essential for the spread of antibiotic-resistant genes. While these factors must function alongside ubiquitous NusG, it is not yet known if their recruitment to RNAP is regulated by autoinhibition and if they can undergo transformation similarly to RfaH.

Broader impacts {#SEC4-3}
---------------

The presence of autoinhibited proteins in key cellular signaling and virulence pathways and their association with a plethora of pathological conditions underlies the importance of better understanding their evolution, diversification, and regulation. Here we have combined experimental and computational techniques into an approach that can quantitatively and directly assess IDI stability and the primary determinants thereof, allowing the unification and synthesis of disparate lines of evidence and showing a path towards the rational alteration or disruption of autoinhibited proteins for anti-virulent and other therapeutic ends.
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